MYX mayne pharma group limited
Add to My Watchlist 1.36% ! $5.08

Ann: SUBA-Itraconazole NDA accepted for review by US FDA, page-2

  1. AngryPrawn
    709 Posts.
    lightbulb Created with Sketch. 95
    clock Created with Sketch.
    02/05/18
    09:42
    Post #: 32818975
    Summary -

    The USA FDA has permitted MYX to lodge an application for approval for selling a medication they already sell around the world. There is no impact on share price and no new sales expected until the FDA issues this approval.
    MYX Price at posting: 69.5¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS The 10 hot stocks HotCopper users watchlisted in Week 30
right-arrow Created with Sketch.
NEWS Exclusive Pre-IPO & Investment Opportunities in Australia & North America
right-arrow Created with Sketch.
NEWS LISTEN NOW: HotCopperWire, our market watch podcast!
right-arrow Created with Sketch.
NEWS 'Strong succession': WiseTech brings in old face to build new, post-White future
right-arrow Created with Sketch.
NEWS Firetail scoops up untested land around Excelsior – including juicy mineralisation target
right-arrow Created with Sketch.
NEWS Harness the power of Australia’s leading investor community
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$5.08 		Change
-0.070(1.36%) 		Mkt cap ! $411.9M
Open High Low Value Volume
$5.05 $5.09 $5.05 $3.991K 788

Buyers (Bids)

No. Vol. Price($)
5 3158 $5.06
 

Sellers (Offers)

Price($) Vol. No.
$5.08 244 4
View Market Depth
Last trade - 11.05am 31/07/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.